GlassScriptPhysician profile
Craytonia Davis
NPI 1528078102
$1,347.56
in general payments reported to CMS, 2019-2025
17 companies · $513 in 2025
The $513 reported for 2025 was more than what 94% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $243 · 2022: $179 · 2023: $158 · 2024: $255 · 2025: $513.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $925.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $925.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $293.72 | 2019-2022 | |
| Corium, LLC | $218.51 | 2023-2025 | Azstarys |
| Alk-Abello, INC | $130.08 | 2024-2025 | Neffy, Grastek, Ragwitek |
| Cranial Technologies, INC | $118.24 | 2019-2025 | Doc Band |
| Ars Pharmaceuticals Operations, INC. | $110.71 | 2025 | Neffy |
| Pfizer INC. | $84.43 | 2019-2024 | |
| Novo Nordisk INC | $71.34 | 2025 | |
| Merck Sharp & Dohme LLC | $61.02 | 2024-2025 | Vaxneuvance, Gardasil 9, Gardasil |
| Sanofi Pasteur INC. | $52.46 | 2022-2024 | |
| Neos Therapeutics, LP | $36.57 | 2023-2025 | Cotempla Xr-Odt |
| Phadia US INC. | $35.34 | 2023-2024 | Immunocap |
| Takeda Pharmaceuticals U.S.A., INC. | $34.55 | 2025 | Vpriv |
| Vertical Pharmaceuticals, LLC | $27.79 | 2024 | Relexxii |
| Sobi, INC | $20.30 | 2023 | |
| Aytu Biopharma, INC. | $19.84 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $16.59 | 2025 | Jornay Pm |
| Glaxosmithkline, LLC. | $16.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craytonia Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.